Showing results (291-300 of 347) with videos related to

Sort By:
Pageof 35
Clinical Genetics|August 3, 2019
Genetic spectrum and clinical profiles in a southeast Chinese cohort of Charcot-Marie-Tooth diseaseCong-Xin Chen, Hai-Lin Dong, Qiao Wei, et al.
International Journal of Molecular Sciences|December 9, 2016
The Coexistence of Hypertension and Ovariectomy Additively Increases Cardiac ApoptosisYi-Yuan Lin, Yu-Jung Cheng, Jun Hu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2004
Hyplip2, a new gene for combined hyperlipidemia and increased atherosclerosisXuping Wang, Peter Gargalovic, Jack Wong, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|March 24, 2006
[Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance]Jin-Tian Li, Li Fu, Jian-Chuan Xia, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 20, 2025
Arbitrarily Shapeable Couplant with Fluidity Onset for Conformal UltrasoundJian Chen, Youlong Hua, Binjie Jin, et al.
Meta Gene|June 23, 2016
ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in ChineseChengjun Sun, Haiyan Wei, Xiuli Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2017
Inhibition of invasion by N-trans-feruloyloctopamine via AKT, p38MAPK and EMT related signals in hepatocellular carcinoma cellsZhong-Tian Bai, Zheng-Rong Wu, Li-Li Xi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapyLi-Xi Liao, Xiao-Min Song, Li-Chao Wang, et al.
Heliyon|June 24, 2024
Naringenin enhances the efficacy of ferroptosis inducers by attenuating aerobic glycolysis by activating the AMPK-PGC1α signalling axis in liver cancerYong-Zhuo Li, Jing Deng, Xiao-Dong Zhang, et al.
The Lancet. Rheumatology|January 27, 2024
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group studyChristopher Tehlirian, Elena Peeva, Elizabeth Kieras, et al.
Pageof 35